NFKB1 and posterior cortical atrophy: Evidence-based studies showed that melatonin's antitumor and antiproliferative effects in PCa cells are medicated by increasing cAMP [39] and inhibiting NF-κB transcriptional activity and integrin α2β1 expression via the MT1 signaling pathway [40].